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Following injury, axons of the peripheral nervous system have retained the capacity for regeneration. While it
is well established that injury signals require molecular motors for their transport from the injury site to the
nucleus, whether kinesin and dynein motors play additional roles in peripheral nerve regeneration is not well
understood. Here we use genetic mutants of motor proteins in a zebrafish peripheral nerve regeneration
model to visualize and define in vivo roles for kinesin and dynein. We find that both kinesin-1 and dynein are
required for zebrafish peripheral nerve regeneration. While loss of kinesin-1 reduced the overall robustness of
axonal regrowth, loss of dynein dramatically impaired axonal regeneration and also reduced injury-induced
Schwann cell remodeling. Chimeras between wild type and dynein mutant embryos demonstrate that dynein
function in neurons is sufficient to promote axonal regrowth. Finally, by simultaneously monitoring actin and
microtubule dynamics in regenerating axons we find that dynein appears dispensable to initiate axonal
regrowth, but is critical to stabilize microtubules, thereby sustaining axonal regeneration. These results reveal
two previously unappreciated roles for dynein during peripheral nerve regeneration, initiating injury induced
Schwann cell remodeling and stabilizing axonal microtubules to sustain axonal regrowth.
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ABSTRACT 
THE ROLE OF MOLECULAR MOTORS IN PERIPHERAL NERVE REGENERATION 
Melissa Ducommun Priest 
Michael Granato 
Following injury, axons of the peripheral nervous system have retained the capacity for 
regeneration. While it is well established that injury signals require molecular motors for their 
transport from the injury site to the nucleus, whether kinesin and dynein motors play additional 
roles in peripheral nerve regeneration is not well understood. Here we use genetic mutants of 
motor proteins in a zebrafish peripheral nerve regeneration model to visualize and define in vivo 
roles for kinesin and dynein. We find that both kinesin-1 and dynein are required for zebrafish 
peripheral nerve regeneration. While loss of kinesin-1 reduced the overall robustness of axonal 
regrowth, loss of dynein dramatically impaired axonal regeneration and also reduced injury-
induced Schwann cell remodeling. Chimeras between wild type and dynein mutant embryos 
demonstrate that dynein function in neurons is sufficient to promote axonal regrowth. Finally, by 
simultaneously monitoring actin and microtubule dynamics in regenerating axons we find that 
dynein appears dispensable to initiate axonal regrowth, but is critical to stabilize microtubules, 
thereby sustaining axonal regeneration. These results reveal two previously unappreciated roles 
for dynein during peripheral nerve regeneration, initiating injury induced Schwann cell remodeling 
and stabilizing axonal microtubules to sustain axonal regrowth. 
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CHAPTER 1: INTRODUCTION 
Peripheral nerve regeneration: a clinical concern 
Peripheral nerve degeneration results from injury or disease and is termed peripheral 
neuropathy. In both of these instances, axons undergo a highly stereotyped 
degeneration program known as Wallerian degeneration. The degeneration of peripheral 
axons leads to sensory and/or motor loss as these neurons lose the connection to their 
functional targets. Some peripheral neuropathies are inherited genetic conditions, 
including the most common form called Charcot-Marie-Tooth disease (CMT), affecting 1 
in 2,500 patients in the United States. Peripheral neuropathies can also be acquired, 
including causes such chemotherapy treatments, diabetes, and peripheral nerve injuries.  
While axons of the peripheral nervous system (PNS) have much greater capacity for 
regrowth than those of the central nervous system (CNS), it is still estimated that fewer 
than 10 percent of patients recover full function after peripheral nerve injury (1). There 
are a number of challenges that peripheral nerves encounter during the process of 
regeneration. First, the distances across which axons must regrow are typically quite 
large in an adult human, and the speed at which peripheral axons regrow is not often 
sufficient to reach the appropriate target organs. Additionally, this slow regrowth leaves 
Schwann cells in the distal stump denervated for prolonged periods of time, and without 
trophic signals from innervating axons this results in Schwann cell loss.  
In addition to the rate of regrowth, the direction of regrowth is also a concern for 
functional regeneration. During peripheral nerve regeneration, axons must navigate back 
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toward their original targets in an environment that is very different from that of the 
developing embryo, when axons initially find their targets. The ease of pathfinding 
depends on the nature of the injury–in crush injuries, the axons distal to the injury site 
degenerate but the nerve tube stays in place, leaving an existing pathway for the 
regrowing axons to follow back to their appropriate targets. In transection injuries, the 
axons, Schwann cells, and basal lamina of the nerve tube are all disrupted and an 
acellular transection gap must be traversed by axons in order for them to regrow in the 
proper direction. This pathfinding task is much more complex, requiring more active 
guidance of regrowing axons, and results in further reduced target innervation after this 
type of injury. Further studies elucidating the cellular and molecular mechanisms that 
promote axonal regrowth and guidance may reveal potential therapeutic targets for 
human peripheral neuropathies.  
While the field of peripheral nerve regeneration is far too large to be covered in single 
section here, I have included a collection of reviews that discuss the current state of the 
field (Table 1.1).  
Neuron-intrinsic mechanisms of nerve regeneration 
In recent years, several key neuron-intrinsic regulators of axonal regrowth have been 
identified. Some of these signals are positive regulators, such as DLK, which has been 
identified as critical in promoting axonal regrowth in both C. elegans motor neurons (2) 
and the mouse sciatic nerve (3). In the central nervous system, several negative 
regulators have been identified as intrinsic, inhibitory factors in axonal regrowth. Neuron-
specific deletion of either PTEN or SOCS3 was found to improve axonal regrowth in the 
3 
 
optic nerve (4,5), and co-deletion of these two factors further increased axonal regrowth 
after injury (6). These experiments demonstrate that intrinsic axonal regrowth potential 
can be modulated by both activation of positive regulators, as well as downregulation of 
pathways that inhibit axonal regrowth.  
Neuron-extrinsic mechanisms of nerve regeneration 
In addition to neuron intrinsic mechanisms, there are critical extrinsic mechanisms that 
also promote nerve regeneration. The difference in regenerative capacity between axons 
of the CNS and axons of the PNS was once largely attributed to the intrinsic growth 
capacity of the neuron (7).  Seminal experiments in which denervated peripheral nerve 
stumps were grafted into an injured spinal cord revealed that axons of the CNS have the 
capacity to regrow when surrounded by the environment of the PNS (7,8). This 
demonstrated that a combination of inhibitory factors in the CNS environment and 
growth promoting factors in the PNS environment contribute to the difference in 
regeneration observed in CNS and PNS axons. 
Many of the extrinsic factors involved in regeneration come from surrounding cell types 
in the nerve. Schwann cells are the primary glia of the peripheral nervous system, 
residing in close proximity to axons. The majority of Schwann cells associate with a 
single axon, ensheathing the axon in tight wraps of myelin in a process known as 
myelination (9). Schwann cells provide neighboring axons with trophic support important 
for axonal maintenance and repair. Mice lacking Schwann cells exhibit early-onset 
axonal neuropathy, indicating a requirement for Schwann cells in axonal maintenance 
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(10). In addition to myelinating Schwann cells, there are also non-myelinating (Remak) 
Schwann cells (11) and perineural ensheathing glia (12) in peripheral nerves.  
In response to injury, both myelinating and non-myelinating Schwann cells in the distal 
nerve stump dedifferentiate to a regeneration-promoting state and form bands of 
Bungner (13,14). Schwann cells in the bands of Bungner proliferate and provide growth-
promoting factors, such as NGF, BDNF, and FGF, to regrowing axons (15-17).  As 
regrowing axons enter the distal nerve stump, Schwann cells and their associated basal 
lamina serve as a scaffold to guide axons toward their original targets (18). Once these 
newly regrown axons arrive at their targets, Schwann cells stabilize and remyelinate 
them (19). In addition to promoting growth in the peripheral nervous system, Schwann 
cells transplanted into the central nervous system also promote axonal growth and 
remyelination, suggesting that Schwann cells have therapeutic applicability (20-22). 
Perineural glia have also recently been shown to play a role in nerve regeneration, 
helping to engulf axonal debris and bridging the transection gap to promote axonal 
regrowth (23). 
In addition to non-neuronal cell types, extracellular molecules are other neuron-extrinsic 
factors that help promote nerve regeneration. Our lab previously identified a pathway by 
which glycosylated collagens help to specifically scaffold signaling molecules in order to 
direct axonal regrowth in vivo (24). This highlights the value of studying nerve 
regeneration in a system in which the behavior of both axons and Schwann cells can be 
experimentally modified and visualized in a whole organism context, as such axonal 
regrowth occurs through a fully in vivo environment.  
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Microtubules and associated motors in nerve maintenance and regeneration 
Mutations in microtubule associated proteins and motors have widely been identified as 
causing neurodegenerative conditions, which highlights the importance of microtubules 
and associated transport functions in neuronal health (Table 1.2).  Microtubules are a 
key component of the cytoskeleton, and these filaments consist of α-tubulin and ß-
tubulin heterodimers arranged in a 13-protofilament lattice.   Axonal microtubules have 
uniform polarity, with the minus ends toward the cell body and the plus ends toward the 
synaptic terminals (25). As is the case in other cell types, microtubules in the neuron are 
nucleated at the centrosome, from which they are transported in a dynein-dependent 
manner into the axon (26-28). Microtubule organization is critical to axon formation and 
stability–microtubules demonstrate increased stability in axons and it was also found that 
microtubule stabilization is sufficient to induce axon formation (29). 
Microtubules serve not only to provide structural support to the cell, but also as tracks for 
active transport within the cell. Microtubule-associated motors move along microtubules 
in a polarity-dependent manner. Kinesins are a large family of microtubule-associated 
motors that move toward microtubule plus ends. Kinesin-1 is the conventional kinesin 
and is composed of two light chains and two heavy chains – the heavy chains make up 
the motor domain while the light chains are responsible for cargo binding and regulation 
(30). Cargos of kinesin include organelles, proteins and RNAs (31). Kinesin-1 is critical 
for neuronal maintenance, as mouse knockouts of various heavy chains cause neuronal 
loss and dysfunction (32,33). Furthermore, human mutations in the kinesin-1 heavy 
chain gene KIF5A have been found to cause a form of hereditary spastic paraplegia 
(34,35), as well as Charcot-Marie-Tooth type 2 (36).  
6 
 
In addition to its role in neuronal homeostasis, kinesin-1 is also involved in axonal 
outgrowth during both development and regeneration.  During development, kinesin-1 
binds and slides microtubules against one another, termed microtubule sliding (Figure 
1.2). This activity had been found to drive major cell shape changes, and to specifically 
drive both dendritic and axonal extension in neurons (37,38). After axonal injury, it was 
found that kinesin-1-powered microtubule sliding is similarly required for axonal regrowth 
(39). 
The complementary motor to kinesin is dynein, a minus end-directed motor protein that 
is responsible for all retrograde transport in neurons, carrying similar cargos such as 
mitochondria, signaling endosomes, and autophagosomes. Dynein is a large protein 
complex comprised of many subunits, with two homodimerizing heavy chains at the core 
of the complex. The heavy chain contains the microtubule binding domains, ATPase 
activity, as well as subunit interacting domains. The light and intermediate chains help 
confer cargo specificity and stabilization to the dynein complex (40). Previously, three 
mouse mutants with distinct dominant mutations in the singular dynein heavy chain, 
dync1h1 (Loa, Cra and Swl), were identified in forward genetic screens as having 
progressive motor or sensory neuron loss (41,42). Moreover, human patients with 
heterozygous mutations in DYNC1H1 experience progressive motor neuron loss, with 
multiple mutations now found to cause spinal muscular atrophy, lower extremity 
dominant (SMA-LED) and Charcot-Marie-Tooth disease (CMT) (43,44). These findings 
have underscored the importance of dynein-mediated transport in neuronal development 
and maintenance. Dynein has also been found to organize the cytoskeleton during 
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axonal outgrowth by transporting microtubules in a polarity-sorting manner to establish 
uniform microtubule polarity in the axon (45).  
In addition to its role in neuronal maintenance, dynein has also been found to have a 
critical role in the neuron after injury. Following injury, one of the most important cellular 
changes within the neuron is the cell body response. This response consists of structural 
changes to organelles in the soma, as well as an increase in transcription and translation 
(46,47). The cell body response is elicited by both negative and positive injury signals. 
Negative injury signals result from a lack of target-derived trophic factors from the 
disconnected, distal axon. For example, retrogradely transported NGF decreases 10-fold 
after transection (48).  
Conversely, positive injury signals are carried back to the cell body from the site of 
injury. One such signal is the phosphorylation of MAP kinases, Erk1 and Erk2. These 
activated MAPKs are carried retrogradely to the cell body linked to dynein through the 
intermediate filament vimentin (49). Once in the cell body, injury signals up-regulate 
regeneration associated genes, which promote axonal regrowth.  These studies 
demonstrate the importance of retrograde signaling within the neuron following nerve 
injury. 
While studies have previously demonstrated key roles for kinesin-1-powered microtubule 
sliding and dynein-dependent injury signaling after axonal injury, both of these motors 
bind many cargos and have multifaceted roles within the cell. This raises the possibility 
that kinesin-1 and dynein may have additional functions after injury. Furthermore, the 
studies of kinesin-1 and dynein function after axonal injury have lacked analysis of in 
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vivo dynamics in a multicellular environment, including the dynamics of regrowing axons 
themselves and the role of surrounding Schwann cells as my work demonstrates. 
Zebrafish as a model to study nerve regeneration in vivo 
In order to dissect the cellular and molecular mechanisms of peripheral nerve 
regeneration in vivo, we use the zebrafish larvae 5 days post-fertilization (dpf). At this 
stage, the larvae are optically clear which allows for in vivo imaging of nerves in the 
context of a live vertebrate animal. At 5 dpf, the nervous system is already fairly mature 
– motor axons have fully extended, formed functional connections with their muscle 
targets, and are myelinated by Schwann cells (50,51). Using combinations of transgenic 
lines in conjunction with live cell imaging, we can monitor interactions between relevant 
cell types, such as motor neurons and Schwann cells (Figure 1.3, 52). We use laser 
mediated axotomy to fully transect motor nerves, which is followed by Wallerian 
degeneration and functional regeneration, and combine this with the use of genetic 
mutants to assess the requirements of a cell type or signaling pathway. Using this 
approach, we previously described nerve-macrophage interactions in vivo, revealing a 
novel nerve scanning behavior (51). We have also used this approach to provide the first 
minute-by-minute account of interactions between motor axons and Schwann cells after 
injury in vivo, which revealed a requirement for Schwann cells in guiding axonal regrowth 
(52). Here, we use this system to assess the roles of the motor proteins kinesin-1 and 
dynein in peripheral nerve regeneration in vivo and reveal novel roles for dynein in the 
Schwann cell response to injury and microtubule modulation at the growth cone to 
promote sustained axonal regrowth.  
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Table 1.1: Useful reviews of peripheral nerve regeneration 
Review Notes 
Mechanisms of Disease: what factors limit 
the success of peripheral nerve 
regeneration in humans? (53) 
Summary of clinical challenges 
Retrograde signaling in axonal 
regeneration (54) 
Review of retrograde injury signaling 
Intrinsic control of axon regeneration 
(55) 
Review of neuron-intrinsic mechanisms of 
regrowth 
The repair Schwann cell and its function 
in regenerating nerves (56) 
Review of Schwann function after injury  
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Table 1.2: Human disease-causing mutations in microtubule-associated proteins 
Gene Disease Reference 
MAPT (microtubule-
associated protein tau) 
Alzheimer’s disease (57-60) 
SPAST/SPG4 (spastin, 
microtubule severing 
protein) 
Upper motor neuron 
diseases 
(61,62) 
DCTN1 (dynactin subunit 
1) 
Perry syndrome; lower 
motor neuron disease 
(63,64) 
KIF5A (kinesin heavy 
chain isoform 5A) 
Hereditary spastic 
paraplegia (SPG10) 
(34,65) 
KIF1Bß (mitochondrial 
transport kinesin) 
Charcot-Marie-Tooth 
Disease 
(66) 
DYNC1H1 (cytoplasmic 
dynein 1 heavy chain 1) 
Charcot-Marie-Tooth 2O; 
Spinal muscular atrophy 
(43,44) 
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Figure 1.1: Schematic of peripheral nerve injury and regeneration. (A) Anatomy of 
an uninjured peripheral nerve. A long axon extends from the cell body of the neuron to 
synapse with a target cell (target not shown). The axon is ensheathed in myelinating 
Schwann cells. Red dashed line indicates site of transection. (B) Peripheral nerve after 
injury and axon fragmentation. Distal section of the axon fragments and distal Schwann 
cells dedifferentiate to a repair cell state. (C) Proximal axon section sprouts a growth 
cone that navigates back towards the denervated distal nerve and original target.  
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Figure 1.2: Schematic of microtubule sliding by motors kinesin-1 and dynein. (A) 
Kinesin-1 slides microtubules with their minus ends out into the axon. (B) Dynein slides 
microtubules with their plus ends out into the axon, and can also slide minus end out 
microtubules back towards the cell body. 
13 
 
 
Figure 1.3: Zebrafish as a model for peripheral nerve regeneration in vivo. Adapted 
from Rosenberg et al., 2014 (A) 5 dpf zebrafish larvae with motor nerves labeled by 
Tg(mnx1:GFP) (green). White box magnified in panels B-E. (B-E) Motor nerve, with 
axons in green and Schwann cell membranes in magenta. Scale bar = 10 µm. Red box 
indicates site of transection. Motor nerve uncut (B), 6 hours post-transection (C), 24 
hours post-transection (D), and 48 hours post-transection (E).  
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CHAPTER 2: KINESIN-1 AND DYNEIN IN NERVE REGENERATION 
Axons of the mature peripheral nervous system have retained a remarkable ability for 
regeneration. Although simple in concept, peripheral nerve regeneration is a complex 
process that requires extrinsic as well as intrinsic mechanisms. Chief amongst the 
intracellular mechanisms that contribute to axonal regeneration are microtubule 
organization and dynamics as well as axonal transport. It has long been known that 
following injury the pool of dynamic microtubules at the lesion site, as well as axonal 
transport, increase (67-69). Given the central role of both microtubule dynamics and 
axonal transport in promoting axonal regeneration, factors that regulate both processes 
are prime candidates for regulating peripheral nerve regeneration.  
The molecular motor proteins kinesin-1 and dynein are key regulators of both 
microtubule organization and axonal transport, and have both been implicated in 
peripheral nerve regeneration. Kinesin-1 is an anterograde motor that is essential for 
maintaining neuronal homeostasis by transporting cargos, including organelles and 
mRNA, from the cell body toward synaptic terminals. Kinesin-1 has also been shown to 
drive axonal outgrowth during development and after injury (38,39). Dynein has similarly 
been studied for its role in maintaining homeostasis by transporting cargo, however 
dynein moves cargo retrogradely towards the cell body. Dynein also plays an important 
role in axonal injury by trafficking injury signals, including components of JNK and ERK 
MAPK pathways, which are generated at the lesion site and actively transported to the 
cell body (70,71). There these injury signals initiate a regenerative response, 
characterized first by upregulation of regeneration-associated genes that prevent 
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neuronal cell death, and by initiating a genetic program that promotes regrowth of injured 
axons back to their original targets (72,73).  
More recently it has become clear that in addition to its role in retrograde transport, 
dynein also functions in cytoskeletal organization and maintenance. For example, in C. 
elegans dynein regulates local microtubule dynamics in dendrites to promote 
microtubule stabilization (74). Additionally, in the axon dynein transports microtubules to 
establish and maintain microtubule polarity (28,45,75). Finally, besides its preeminent 
role in axonal homeostasis, dynein is also required for Schwann cell development and 
myelination (76). Yet despite dynein’s well documented roles in both axons and glial 
cells, the effects of dynein on the cellular behaviors of regenerating axons and their 
associated glial cells in intact animals have not been examined.  
In order to examine the diverse cellular functions of molecular motors in multiple cell 
types, we combined genetic mutants with live imaging of nerve regeneration in larval 
zebrafish, as previously described (51). This allowed us to study the real-time dynamics 
of regenerating axons and surrounding Schwann cells in a whole organism context. We 
find that the molecular motors kinesin-1 and dynein, albeit to different degrees, are both 
required for axonal regrowth in vivo and that dynein is also required to initiate injury-
induced morphology changes in Schwann cells. We show that wild type neurons 
transplanted into otherwise dynein mutant animals are able to regrow robustly, indicating 
that neuronal dynein is sufficient to promote axonal regrowth. Finally, we find that dynein 
is dispensable for initiation of axonal regrowth but is required to stabilize microtubules in 
injured axons to generate persistent, long-range regrowth. These findings elucidate 
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previously unknown roles for dynein in the initiation of injury-induced Schwann cell 
behaviors, and identify a distinct role for dynein in promoting axonal regeneration 
through persistent axonal regrowth via microtubule stabilization.  
Kinesin-1 and dynein are critical for peripheral nerve regeneration in vivo 
To determine the in vivo roles of molecular motors in peripheral nerve regeneration, we 
first assessed regeneration in mutants lacking kif5aa, which encodes the neuron-specific 
Kif5A heavy chain of the conventional anterograde motor kinesin-1. We have previously 
shown that laser mediated transection of motor nerves in larval zebrafish initiates a 
Schwann cell dependent peripheral nerve regeneration program reminiscent of what is 
observed in adult vertebrate (52). Following their complete transection at 5 days post-
fertilization (dpf), ventral motor nerves exhibit Schwann cell dependent functional 
regeneration by 48 hours post- transection (hpt) (Figure 2.1, A-B, 52). Prior to 
transection, kif5aa-/- motor nerves were indistinguishable from wild type nerves (Figure 
2.1, C). By 48 hpt, motor axons in kif5aa-/- mutants had regrown across the full extent of 
the ventral myotome, although when compared to wild type siblings the number of 
fascicles that reached their ventral targets was reduced (Figure 2.1, D-E). Using a 
previously established semi-quantitative scoring index (for details see materials and 
methods and (52) we confirmed that compared to wild type siblings, motor axons in 
kif5aa mutants exhibited reduced regeneration (p=0.0487, Fisher’s exact test).  
We next assessed motor axon regeneration in genetic mutants for the dynein heavy 
chain gene (dync1h1) which encodes a core component of the retrograde motor dynein. 
These mutants survive through development due to maternally deposited dynein, which 
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persists until 4 dpf (77). This allows the fish to develop normally but have minimal levels 
of dynein at 5 dpf when we perform nerve transection assays. Importantly, this 
dync1h1hi3684 allele is a presumed null, unlike human mutations in DYNC1H1 which have 
been found to be dominant gain of function alleles (43,44).  
Prior to injury at 5 dpf, dync1h1-/- motor axons exhibit normal architecture, presumably 
due to the large maternal load sufficient to promote axonal development ((77), Figure 
2.1, F). In contrast, following transection, motor axons in dync1h1-/- mutant animals 
frequently failed to extend beyond the transection site (Figure 2.1, G; quantified in Figure 
2.1, H). Analysis of dynein heterozygotes revealed a less severe defect in axonal 
regrowth (p=0.0745), demonstrating a dose-dependent requirement for dynein in 
promoting axonal regrowth. The severity of the regeneration phenotype we observed in 
homozygous dync1h1-/- mutants was significantly stronger than that present in kif5aa-/- 
mutants (p<0.0001 and p=0.0487, respectively). This is consistent with the notion that 
other heavy chains of kinesin-1 as well as other kinesin family motors might compensate 
for the absence of kif5aa (78). In contrast, dynein is the sole protein responsible for 
microtubule-associated retrograde transport, and therefore the regeneration phenotype 
we observe in homozygous mutants likely represents a complete block of retrograde 
transport. We therefore focused on further defining the role of dynein in peripheral nerve 
regeneration.  
Dynein mutant motor neurons persist in 5 dpf larvae 
After finding that dynein mutants have impaired axonal regrowth when injured at 5 dpf, 
we next wondered whether this was truly a result of decreased regenerative capacity of 
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the dynein mutant axons, or whether there was a reduction in the number of motor 
neurons in a 5 dpf mutant larvae that caused fewer motor axons to regrow. It is possible 
that the lack of dynein in motor neurons is lethal to the cells, so we performed TUNEL 
staining in uninjured larvae at 5 dpf to determine whether there was increased cell death 
of motor neurons in the dynein mutants (Figure 2.2, A). In the wild type siblings, very few 
TUNEL positive cells were observed across the spinal cord, and no TUNEL positive cells 
were labeled in the ventral spinal cord where the motor neurons reside (Figure 2.2, B). In 
dynein mutant larvae, an increased number of TUNEL positive cells were observed in 
the spinal cord, indicating that there is some general increase in cell death in the 
mutants. To determine whether any of this cell death was in motor neurons, we 
quantified the number of TUNEL positive cells in the ventral spinal cord and found that 
this number was minimal (4 TUNEL+ cells across 36 hemisegments). Additionally, none 
of the TUNEL+ cells colocalized with the motor neuron label (tg(mnx1:GFP)), so we 
concluded that while the dynein mutants exhibited an increase in cell death at 5 dpf, this 
does not affect the motor neuron population (quantified in Figure 2.2, D). This indicates 
that rather than a lack of viable motor neurons to regrow axons, motor neurons persist in 
dynein mutant larvae at 5 dpf and the decreased regeneration observed in dynein 
mutants is in fact a defect specific to the process of axonal regrowth.  
Dynein is required for injury-induced Schwann cell remodeling  
In addition to its well-studied function in neurons, dynein is also required for proper 
differentiation and myelination of Schwann cells during development (14). Furthermore, 
in zebrafish lacking Schwann cells, regenerating axons sprout from the proximal nerve 
stump but fail to grow across the injury gap (20), somewhat reminiscent of the 
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phenotype we observe in dynein mutants. Given the importance of Schwann cells for 
peripheral nerve regeneration and the role of dynein in Schwann cell development, we 
sought to determine whether dynein is also required for the Schwann cell response to 
injury, characterized by stereotyped changes in Schwann cell morphology.  
We have previously shown that before injury, Schwann cell membranes ensheathe 
individual motor axons, and that following post-injury axonal fragmentation, Schwann cell 
membranes reorganize, changing from a smooth, tube-like appearance to a more 
rounded and granular morphology (20), indicative of their transition to an activated, 
dedifferentiated state—known as the repair cell state—that promotes axonal 
regeneration. Previous studies revealed that in dynein mutants, Schwann cells 
development prematurely arrests at the promyelinating stage (14). We therefore first 
wanted to determine whether immature Schwann cells are able to respond appropriately 
to injury. For this we examined a mutant for the G-protein coupled receptor GPR126, in 
which Schwann cells also arrest at the promyelinating stage (21), similar to what has 
been reported for dync1h1 mutants. Analysis of gpr126 mutants revealed that Schwann 
cells respond to injury by extending their membranes dramatically compared to their pre-
injury state, indistinguishable from wild type Schwann cells (Figure 2.3, A-D). This 
demonstrates that developmentally arrested Schwann cells are still able to respond 
appropriately to nerve injury.  
Having determined that promyelinating Schwann cells are competent to respond 
appropriately to nerve injury, we next examined the behavior of dync1h1-/- mutant 
Schwann cells. Unlike wild type and gpr126 mutant Schwann cells, we find that following 
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nerve transection dync1h1-/- mutant Schwann cells fail to initiate any morphological 
changes, and instead retain their pre-injury morphology and membrane position for the 
duration of the imaging period (up to five hours), arguing against a delay in onset but 
rather for a complete lack to initiate a Schwann cell injury response (Figure 2.3, E-F). To 
quantify this phenotype, we measured the changes in Schwann cell width following 
nerve transection as a simpler proxy for the complex changes in Schwann cell 
morphology (Figure 2.3, G). This revealed that while wild type and gpr126-/- Schwann 
cells significantly increase in width after injury, dync1h1-/- Schwann cells show no 
significant change. Thus, while dync1h1-/- mutant axons initiate fragmentation following 
injury, their associated Schwann cells fail to respond, consistent with the idea that 
dynein is critical for injury-induced Schwann cell remodeling.  
Neuronal dynein is sufficient to promote axonal regrowth  
Our results reveal injury-induced phenotypes in two cell types after injury in dynein 
mutants, and we therefore wondered whether dynein functions in neurons or Schwann 
cells to promote axonal regrowth. To determine the cell type in which dynein functions to 
promote axonal regrowth, we generated blastula stage chimeras (27) that contained wild 
type motor neurons and axons in otherwise dync1h1-/- larvae (Figure 2.4, A-B). Control 
transplantations have previously shown that wild type cells transplanted into wild type 
embryos generate motor neurons that are morphologically and functionally unaffected by 
transplantation (22). Following development and subsequent transection in a dync1h1-/- 
environment, wild type axons were able to regenerate robustly for the first 9 hours after 
sprouting (Figure 2.4, C-F), in a manner indistinguishable from wild type axons in a fully 
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wild type environment. This indicates that restoring dynein specifically in neurons in a 
dynein mutant is sufficient to promote axonal regrowth, demonstrating a neuron-intrinsic 
role for dynein during peripheral nerve regeneration. While technical considerations 
prevented us from visualizing Schwann cells in chimeric nerves, it is unlikely that wild 
type axonal regrowth would rescue dynein mutant Schwann cell response to injury, as 
these processes are temporally distinct—Schwann cells respond to injury between 2 and 
4 hours post transection, while axons do not begin to regrow until about 9 hours after 
transection.  
Interestingly, we found that dync1h1-/- axons that had wild type axons in the same nerve 
regrew more robustly than dync1h1-/- axons in nerves with no transplanted cells (14.23 
± 2.06 μm growth in dync1h1-/- larvae without transplants, see below; 39.33 ± 4.72 μm 
growth in dync1h1-/- larvae with transplants; Figure 2.4, F). In several instances, we 
observed dync1h1-/- axons growing along previously extended wild type axons (Figure 
2.4, G-I). This indicates that the presence of wild type axonal regrowth is able to partially 
rescue the dync1h1-/- axonal regrowth defects. Thus, while dynein acts intrinsically in 
neurons to promote axonal regrowth, it may also play a role in inter-neuronal interactions 
during regeneration. 
Dynein stabilizes axonal growth during regeneration  
We next asked how dynein promotes axonal regeneration within peripheral nerves. 
Peripheral nerve regeneration is a dynamic process composed of several defined 
stages, starting with growth cones emerging from the proximal stump and probing the 
injury gap environment. This is followed by stabilization of axonal regrowth across the 
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injury gap and along the correct trajectory, and finally rapid, sustained axonal regrowth 
towards their original targets (23). We used live cell imaging after nerve transection to 
quantify axonal dynamics in dynein mutants and determine which of these stages 
require dynein. In wild type siblings, we observed growth cones emerging from the 
proximal stump extending (3.54 events per 8 hours) and retracting (1.08 events per 8 
hours) repeatedly, consistent with the idea that these growth cones are probing the 
injury gap for a path towards their original targets (Figure 2.5, A-B). We found that 
dync1h1-/- axons exhibit similar frequencies of axonal extensions and retractions (Figure 
2.5, C-D), suggesting that they probe the injury gap as actively as their wild type siblings 
(Figure 2.5, E).  
We next examined the second stage of axonal regeneration when axons become 
stabilized and then extend toward their original targets. To quantify this process, we 
measured the overall displacement of regenerating growth cones over the first ~8 hours 
after sprouting began. We found that the majority of regenerating wild type axons grew 
beyond the transection site within 8 hours of sprouting (Figure 2.5, F), travelling an 
average of 41.49 μm (SEM ± 5.84) over this time period. In contrast, regenerating 
dync1h1-/- axons rarely extended beyond the transection site (Figure 2.5, G), travelling 
an average of 14.23 μm (SEM ± 2.06) and never exceeding 21.94 μm in growth. 
Moreover, quantification of growth cone displacement at 8 hours post transection 
revealed that compared to regenerating wild type axons, dync1h1-/- axons exhibited a 
significant decrease in axonal extension (Figure 2.5, H). Combined these results argue 
that rather than initiating growth cone sprouting and short range axonal extensions, 
dynein predominantly acts early during axonal regeneration to stabilize regenerating 
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axons thereby promoting persistent, long-range regrowth.  
Dynein stabilizes microtubules to promote persistent regrowth  
Dynein has recently been shown to play a critical role in generating and maintaining 
microtubule organization, both processes central to axonal growth (10,11,24,25). To 
determine whether dynein regulates microtubule dynamics in axons during regeneration, 
we used a transgenic line that simultaneously labels actin and microtubules in motor 
neurons (mnx1:Gal4; UAS:lifeact-GFP-v2a-EB3-RFP). Growth cone extension occurs in 
three stages: first, protrusion driven by F-actin, then engorgement driven by microtubule-
based transport of organelles and vesicles, and finally consolidation in which the growth 
cone contracts and stabilizes to form a cylindrical axon shaft (26). In regenerating wild 
type axons, filopodia extend at the growth cone and microtubules follow behind, 
stabilizing and consolidating newly formed protrusions (Figure 2.6, A- D). The majority of 
regenerating dync1h1-/- axons (n=30/37) displayed one of two phenotypes characteristic 
for microtubule disruption. In 59 percent (n=22/37) we observed filopodia extension 
followed briefly by microtubule extension (Figure 2.6, E-F) and then arrest at the 
engorgement stage before finally retracting (Figure 2.6, G-H). In 22 percent (n=8/37) of 
regenerating dync1h1-/- axons, microtubules faithfully followed filopodia extending at 
growth cones. However, rather than consolidating in the proximal growth cone, they 
adopted a looped conformation at the leading edge of the growth cone, leading to 
stalling and retraction (Figure 2.6, I-M). This demonstrates that lack of dynein leads to 
loss of microtubule organization at regenerating growth cones and stalling of 
regenerating axons early during the regeneration process. Combined, these findings 
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support a model by which dynein plays a critical role in regulating microtubule dynamics, 
thereby stabilizing growth of regenerating axons as they initiate their trajectory across 
the injury gap and towards their original targets. Our data reveal a critical role for dynein 
in promoting axonal extension via microtubule stabilization, as well as a previously 
uncharacterized role in initiating Schwann cell response to injury.  
Dynein is required for cytoskeletal maintenance in axons 
Given that dynein regulates microtubule dynamics in the axon during regeneration, we 
wondered if dynein was also required for long term maintenance of the axonal 
cytoskeleton. While the homozygous dync1h1 mutants are only viable until 8 dpf, the 
heterozygotes are fully viable into adulthood. This gave us the opportunity to examine 
axons in animals with a reduction in functional dynein levels and determine how this 
effects the cytoskeleton long-term.   
In collaboration with Clara Franzini-Armstrong, we fixed dync1h1 heterozygotes at 2 
months of age (wild type n=2 fish, dync1h1+/- n=2 fish) and performed electron 
microscopy on cross sections of ventral motor nerves. Dissections, fixation and 
sectioning were all performed in parallel across samples. In the wild type siblings, we 
found nicely organized cytoskeletal components within most axons. Elongated 
intermediate filaments were highly ordered and microtubules were apparent in the 
majority of axon sections. In the dync1h1 heterozygotes, most axons contained 
disordered intermediate filaments and many sections lacked apparent microtubules 
(Figure 2.7, quantified in Figure 2.8). This suggests that dynein is required to maintain 
cytoskeletal structure in motor axons.  
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There are several key experiments that should follow up on these preliminary findings – 
first, the initial experiment should be repeated to confirm that the disrupted cytoskeleton 
in dync1h1 heterozygotes is not simply an artifact from fixation and sectioning. While this 
is unlikely due to the number of samples in the first experiment, it would also be an 
extremely surprising finding that adult axons can function with a severely disrupted 
cytoskeleton. Mutations in various cytoskeletal proteins have been found to cause 
severe neurodegeneration in humans, indicating that cytoskeletal structure is critical to 
neuronal maintenance and function (79). 
Another critical question regarding the cytoskeletal defects observed in dync1h1 
heterozygote adults is whether the cytoskeletal structure degenerates over time, or 
whether it is improperly established during development. To distinguish between these 
possibilities, electron microscopy should be performed on dync1h1 heterozygote larvae 
at between 3-5 dpf, after the axonal cytoskeleton is established but likely before any 
cytoskeletal degeneration could occur.  If the axonal cytoskeleton is intact and properly 
organized in the heterozygous larvae, this would suggest that the cytoskeleton develops 
properly despite reduced dynein levels but subsequently degenerates over time, 
indicating that dynein is required for cytoskeletal maintenance. If the axonal cytoskeleton 
is already disordered in the heterozygote larvae, this would indicate that dynein is 
required to establish the cytoskeleton rather than to maintain it.  
Dynein promotes axonal degeneration after injury 
Wallerian degeneration is both a highly stereotyped and highly conserved process, 
occurring in organisms from insects to mammals. Axonal degeneration is initially marked 
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by membrane beading and swelling, followed by rapid breakdown of the cytoskeleton. 
After the axon fragments, surrounding cells, such as Schwann cells and macrophages in 
the peripheral nervous system, engulf and digest cellular debris. While debris clearance 
is dependent on surrounding cell types, axon fragmentation is a neuron-intrinsic event 
(80). It was originally thought that the loss of trophic support following injury caused 
axonal degeneration. However, expression of a novel fusion protein in a spontaneous 
mouse mutant, WldS, was found to protect injured axons from degeneration (81). This 
suggests that axonal death is an active process, rather than a passive, wasting process 
resulting from loss of trophic factors. Furthermore, a more recent study found that a loss 
of function mutation in the protein dSarm results in delayed axonal degeneration. This 
finding demonstrates that there are specific pro-death signals involved in axonal 
degeneration (82). However, axonal death is distinct from apoptotic death as it is 
caspase-independent and localized to the axon, leaving the soma intact (83).   
The cytoskeletal events that occur during axonal degeneration have been well 
characterized. Cytoskeletal breakdown is initiated by both the ubiquitin-proteasome 
system (UPS) and calpain-mediated proteolysis (84,85). These processes are calcium-
dependent and therefore upregulated after injury due to an initial increase in intracellular 
calcium levels. Inhibiting UPS and calpain either directly or through calcium chelation 
delays cytoskeletal breakdown, although it does not prevent initial beading and swelling 
of the axonal membrane (83,84,86). This indicates that there must be additional 
mechanisms of cellular breakdown involved in initiating axon fragmentation that are still 
unknown. 
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To determine whether the motor protein dynein is involved in the process of axonal 
degeneration, we transected nerves in 5 dpf dynein mutant larvae and performed 
timelapse imaging of the distal nerve stump beginning shortly after injury. We found that 
compared to their wild type siblings, dynein mutant larvae exhibited a dramatic increase 
in the time to first axonal fragmentation (Figure 2.9). Given that the time to axonal 
fragmentation increases in the absence of dynein, this demonstrates that dynein 
promotes axonal degeneration in vivo. There are several possibilities of how dynein may 
promote axonal degeneration. Interestingly, when axonal fragmentation begins, the 
entire length of the axon fragments simultaneously (87), suggesting spatial and temporal 
coordination of the fragmentation process. As dynein carries signaling endosomes 
throughout the axon, it is possible that some of these active death signals required for 
Wallerian degeneration may be transported by dynein to properly localize throughout the 
axon after injury and coordinate the initiation of fragmentation. 
Alternatively, it is possible that dynein coordinates some of the mechanical breakdown 
required for the process of fragmentation and degeneration. Dynein is required for 
axonal autophagy as it transports autophagosomes, which are intracellular vesicles that 
form a double membrane that engulfs cytoplasmic contents and delivers them to 
lysosomes for degradation. In neurons, autophagosomes initially form and sequester 
cytoplasmic contents at the distal end of the axon and move retrogradely as they mature 
and ultimately fuse with lysosomes, which are then termed autolysosomes (88). 
Retrograde transport by dynein is critical in mediating encounters between 
autophagosomes and lysosomes to allow for fusion and acidification of autolysosomes 
(89). Though there is evidence for increased autophagy in degenerating neurons 
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(90,91), the transport and function of autophagosomes during axonal degeneration 
remains unclear. Given that dynein mutants exhibit delayed degeneration after injury and 
autophagosomes are a direct cargo for dynein, future experiments should examine 
autophagy in dynein mutant axons to determine whether dynein-dependent transport of 
autophagosomes contributes to axonal degeneration in vivo. 
Taken together, the studies in this chapter reveal for the first time an in vivo requirement 
for the motor proteins kinesin-1 and dynein in nerve regeneration. We also identified 
novel roles for dynein in the process of nerve regeneration, including involvement in 
axonal extension via modulation of microtubule dynamics and initiation of Schwann cell 
morphology changes after injury. Preliminary studies suggest involvement of dynein in 
cytoskeletal maintenance of axons as well as an active role in the initiation of axonal 
fragmentation after injury. Here we have identified that in vivo, dynein promotes axonal 
degeneration, regrowth, and maintenance.  
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Figure 2.1: Dynein and Kinesin-1 are required for peripheral nerve regeneration in 
vivo. (A) Wild type motor nerve pre-lesion (red box, transection site; scale bar = 20 µm). 
(B) By 48 hpt, several fascicles have regrown fully across the ventral myotome (green 
arrowheads, regrown axons, strong regeneration). (C) kif5aa-/- motor nerve pre-lesion. 
(D) At 48 hpt, some axons have extended across the myotome (blue arrowheads, 
regrown axons, moderate regeneration). (E) Quantification of kif5aa mutant regeneration 
at 48 hpt (wild type siblings, n=66 nerves; kif5aa-/-, n=20 nerves, p=0.0487, Fisher’s 
exact test). 
 (F) dync1h1-/- motor nerve pre-lesion. (G) By 48 hpt, regrowing axons have extended 
slightly but failed to reach the ventral extend of the myotome (red arrowheads, stalled 
axons, no/weak regeneration). (H) Quantification of dync1h1 mutant regeneration at 48 
hpt (dync1h1+/+, n=59 nerves; dync1h1+/-, n=21 nerves; dync1h1-/-, n=25 nerves; 
p=0.007; p=0.0006; p<0.0001, respectively, Fisher’s exact test).  
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Figure 2.2: Dynein mutant motor neurons persist in 5 dpf larvae. (A) Schematic of 5 
dpf larvae. Motor neuron cell bodies shown in green, red box indicates area imaged for 
TUNEL quantification. (B-C) TUNEL staining of spinal cord of uninjured larvae at 5 dpf. 
Motor neuron cell bodies labeled in green (mnx1:GFP), TUNEL + cells labeled in red. (B) 
Wild type larvae and (C) dync1h1-/- larvae. (D) Quantification of TUNEL + cells in the full 
spinal cord and ventral spinal cord across 36 hemisegments (n= 3 larvae). 
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Figure 2.3: Dynein is required for injury-induced Schwann cell morphology 
changes. (A-F) Schwann cells in 5 dpf larvae labeled by Tg(sox10:mRFP). (A) Prior to 
injury, wild type Schwann cells have smooth, straight membranes that are tightly 
associated with the axonal track (scale bar = 5 µm). (B) After axonal fragmentation, 
Schwann cell membranes change morphology and widen to accommodate axonal 
debris. (C) Prior to injury, gpr126-/- Schwann cells are loosely associated with axons as 
they do not myelinate. (D) After axonal fragmentation, gpr126-/- Schwann cells are able 
to change morphology and widen. (E) Prior to injury, dync1h1-/- Schwann cells are 
loosely associated with axons as they also do not myelinate. (F) After axonal 
fragmentation, dync1h1-/- Schwann cell membranes maintain an elongated 
conformation and do not dramatically change morphology, indicating a disrupted injury 
response. (G) Quantification of Schwann cell width pre- and post-fragmentation in 
gpr126 and dync1h1 mutants. 
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Figure 2.4: Neuronal dynein is sufficient to promote axonal regrowth. (A) ~10 
rhodamine-labeled cells were transplanted from wild type blastulas to dync1h1-/- 
blastulas. (B) At 5 dpf, nerves contained wild type neurons (transplanted cells labeled by 
rhodamine-dextran, magenta) in a dync1h1-/- larva (host motor neurons labeled by 
Tg(mnx1:GFP), green; scale bar = 10 µm). (C-E) After transection, wild type axons 
(magenta arrowheads) are able to regrow robustly in the dync1h1-/- embryo, while 
dync1h1-/- host axons regrow significantly less (green arrowheads; scale bar = 10 µm). 
(F) Quantification of growth cone displacement in dync1h1-/- host axons and 
transplanted wild type axons. Open circles indicate dync1h1-/- mutant axons that grew 
along transplanted wild type axons. (G-I) Some dync1h1-/- axons demonstrated 
improved regeneration in the presence of wild type axons in the same nerve. Here, a 
dync1h1-/- axon (green arrowheads) follows along a previously regrown wild type axon 
(magenta arrowheads; scale bar = 5 µm).  
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Figure 2.5: Dynein stabilizes axonal extensions during regeneration. (A-B) In wild 
type animals, regenerating axons begin probing the environment by extending and 
retracting (green and red arrowheads, respectively; scale bar = 5 µm). (C-D) dync1h1-/- 
axons also extend and retract after injury. (E) Quantification of extension and retraction 
events in wild type siblings (n=13 axons) and dync1h1-/- axons (n=13 axons). (F-G) 
Measurement of overall growth cone displacement from transection site ~16 hpt in wild 
type siblings (F; blue arrowheads, growth cones; scale bar = 10 µm) and dync1h1-/- (G; 
red arrowheads, growth cones). (H) Quantification of growth cone displacement ~16 hpt 
(wild type siblings, n=15; dync1h1-/-, n=10; p=0.0005, unpaired t-test). 
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Figure 2.6: Dynein stabilizes microtubules to promote persistent regrowth. (A-D) 
Regenerating wild type axons first extend actin protrusions then extended microtubules, 
leading to stable growth (scale bar=5 µm; green arrowheads, actin; magenta 
arrowheads, microtubules). (E-H) dync1h1-/- axons extend actin protrusions followed by 
microtubule growth that arrests during growth cone engorgement and leads to axon 
retraction (G,H). (I-L) dync1h1-/- axons extend actin protrusions but microtubules form 
aberrant loop structures (magenta arrowheads), leading to axonal retraction. (M) 
Quantification of microtubule organization in regrowing axons of dync1h1 mutants 
(siblings, n=19 axons; dync1h1-/-, n=37 axons; p<0.0001, Fisher’s exact test). 
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Figure 2.7: Dynein maintains cytoskeletal structure in motor axons of adult 
zebrafish. (A-D) Cytoskeletal structure of large caliber axon (red outline), scale bar = 
500 nm. Wild type sibling (A,C) and dync1h1+/- (B,D). Red arrows, microtubules; blue 
arrows, intermediate filaments. 
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Figure 2.8: Quantification of cytoskeletal structure in motor axons of adult 
dync1h1+/- zebrafish. (A) Quantification of intermediate filament organization in wild 
type (n=43 axons) and dync1h1+/- (n=33 axons) motor axons. (B) Quantification of 
microtubules present in wild type (n=43 axons) and dync1h1+/- (n=33 axons) axons.  
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Figure 2.9: Dynein promotes axonal degeneration after injury. Time to first axonal 
fragmentation after injury in wild type and dync1h1-/- mutant axons. 
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CHAPTER 3: NOVEL IN VIVO IMAGING APPROACHES 
In vivo imaging of cytoskeletal dynamics in Schwann cells 
Schwann cells are critical in promoting axonal regrowth and nerve regeneration. 
Following nerve injury, Schwann cells distal to the lesion site respond dynamically by 
breaking down their myelin and dramatically altering their morphology. These 
morphological changes are accompanied by changes in transcriptional profile – 
Schwann cells dedifferentiate to a state similar to the immature Schwann cell, termed 
the repair cell, during regeneration. In this pro-regenerative state, Schwann cells can 
engulf axonal debris, migrate, proliferate, and ultimately remyelinate regrown axons. 
Previous work from our lab found that Schwann cells are required for proper axonal 
regrowth in vivo (92). Furthermore, studies transplanting denervated Schwann cells from 
peripheral nerves into CNS injury sites found that Schwann cells are able to promote 
axonal regrowth of CNS axons (7). Despite their therapeutic potential, many questions 
remain regarding the morphological and molecular changes in Schwann cells that 
promote neural repair. Though factors have been identified that initiate Schwann cell 
dedifferentiation after injury (93-95), a comprehensive description of the changes in 
Schwann cell morphology and cytoskeletal organization in vivo is missing, mainly due to 
the technical challenges of imaging regeneration in live intact animals. Similarly, if and to 
what extent changes in the Schwann cell cytoskeleton are critical for axonal 
regeneration is currently unknown. 
Current understanding of the Schwann cell cytoskeleton comes predominantly from 
immunohistochemistry in cultured Schwann cells (96-99). While this has provided some 
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structural information, static images lack dynamic information and indication of 
microtubule polarity. Furthermore, the morphology of Schwann cells in culture can vary 
widely, and these Schwann cells lack association with axons which is a primary 
determinant of morphology in vivo. 
In order to visualize the Schwann cell cytoskeleton in vivo, I specifically examined 
microtubules which are critical in directing and maintaining cell shape. I expressed 
fluorescently labeled EB3, a microtubule plus-end binding protein which marks the 
growing ends of microtubules, in Schwann cells. This allowed me to observe microtubule 
dynamics in Schwann cells live, in real time and importantly also relative to their 
associated axons, which are critical to the complex, three-dimensional morphology of 
Schwann cells in vivo. The in vivo Schwann cell cytoskeleton has not previously been 
described, even in cells before injury, due to the technical challenges of visualizing such 
components in a live animal. I similarly encountered many technical challenges in this 
pursuit, the details of which I will report here. 
The major challenge in visualizing microtubules in Schwann cells of zebrafish larvae was 
expressing this marker in Schwann cells at all. Initially, I tried to use the sox10(7.2kb) 
promoter to drive expression of EB3 in Schwann cells transiently so that I could observe 
individual Schwann cells using the mosaic labeling that results from transient 
expression. When injecting the construct (sox10(7.2kb):EB3-GFP) and looking for 
transient expression, I frequently saw expression in other cell types labelled by sox10, 
as this is a broad marker of neural crest lineage. Across the thousands of fish I have 
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examined for transient Schwann cell expression using the sox10(7.2kb) promoter, I still 
to this day have never seen a Schwann cell labeled transiently.  
My next approach was to generate stable transgenic lines using the sox10(7.2kb) 
promoter, as this promoter has previously been used to successfully generate lines 
labeling Schwann cells in zebrafish (100). I injected the sox10(7.2kb):EB3-GFP 
construct and raised ~100 embryos to adulthood. I then screened for lines that labeled 
microtubules in Schwann cells and identified two separate lines. The first, line 4, labeled 
microtubules at a high enough expression level to easily see comets but not so high as 
to fill the cell with free EB3 (Figure 3.1A). Unfortunately, when I tried to raise this 
identified larvae (and several of its siblings with similar expression patterns) to adulthood 
to maintain the line, they all died. It is possible that even with levels of EB3 that were 
ideal for visualizing microtubules, this still may have negatively impacted microtubule 
dynamics in the neural crest cells of these individuals, causing lethality.  
The second line, line 8, had a slightly lower level of EB3 expression, although comets 
could still be easily visualized before injury (Figure 3.1B). An important point here for the 
purpose of visualizing microtubules after injury is that we use a laser commonly used for 
FRAP analysis to perform our nerve transections. This laser causes photobleaching of 
GFP, which with cytosolic GFP can recover over time as more GFP diffuses from parts 
of the axon that were not cut. It seems, however, that the photobleaching of EB3-GFP 
was much more severe and long-lasting, preventing the visualization of microtubules in 
Schwann cells for a few hours after injury, exactly when the critical morphological 
changes are occurring in Schwann cells.  
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I was able to successfully raise two identified line 8 larvae to adulthood, and outcrossed 
them to a wildtype stain to maintain the line. Unfortunately, when these adults were then 
incrossed, the level of labeled EB3 in Schwann cells was too low to image and quantify. 
This raises another important point about generating transgenic lines in zebrafish: using 
the Tol2 transposase greatly increases the rate of transgenesis, however it does not 
always generate the most reliable stable lines. With Tol2 transgenesis, concatamers of 
the transgene can be formed, meaning that multiple copies of the desired gene may 
integrate into the genome. While this can be helpful for expression levels initially, this 
also means that with subsequent outcrossing, some of these copies are lost, and 
expression level can decrease.  
Given the difficulty of identifying stable transgenic lines with an EB3 expression level 
suitable for imaging before and after injury, I turned to another Schwann cell promoter, 
Claudin K. Claudin K is a myelin-associated protein and thus labels only myelinating 
Schwann cells and oligodendrocytes. Using the CldnK promoter, I was able to see good 
transient expression of EB3 in Schwann cells (Figure 3.1C). The expression pattern 
tends to be clonal for a single nerve, so if one Schwann cell was labeled in a nerve, it 
also usually labeled all of the Schwann cells in that nerve. I also compared this structure 
to acetylated tubulin staining in 5 dpf fixes larvae (Figure 3.1D) and found the live 
images to provide a more defined structure. 
While CldnK was a much more reliable promoter and allowed me to successfully 
express many proteins both transiently and in stable transgenic lines, the most ideal 
levels of EB3 for live imaging in Schwann cells came from expression using stable lines 
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generated with the Gal4/UAS system. I crossed a sox10:Gal4 stable line and with a 
UAS:EB3-GFP line and this yielded bright labeling in most Schwann cells (Figure 3.1E). 
Interestingly, levels of EB3-GFP occasionally varied greatly between Schwann cells of 
the same nerve, allowing for some single cell resolution. The levels of EB3-GFP were 
strong enough to prevent photobleaching after laser transection, which allowed me to 
image cytoskeletal dynamics after injury (Figure 3.1F). 
Going forward, these lines can be used to visualize dynamics of the Schwann cell 
cytoskeleton first in wild type larvae, both before and after nerve injury. This will 
determine how the cytoskeleton changes after injury, as Schwann cells transition from 
their mature, myelinating state into a repair cell state. The lines have also already been 
crossed into a dynein mutant background which will allow us to assess if and how the 
Schwann cell cytoskeleton differs in dynein mutant nerves, both before and after injury. 
One unique challenge for assessing the Schwann cell cytoskeleton in vivo is the 
complex cellular morphology. This dramatically increases the complexity of automatically 
tracking and measuring individual EB3 comets, as many more comets are present 
simultaneously than in a single section of an axon. I have previously used the Imaris 
software to automate the tracking of EB3 particles, and have had moderate success with 
the automatic “track particles” feature. It is likely that a more specific protocol will be 
needed to accurately track and measure the microtubule dynamics in Schwann cells. 
This preliminary data represents the first visualization of the Schwann cell cytoskeleton 
in a live, whole organism context.  
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In vivo imaging of nerve regeneration in midlarval zebrafish 
The early larval zebrafish is an excellent system for studying nerve regeneration, as the 
larvae are optically clear at 5 dpf, allowing for in vivo imaging of cellular interactions after 
injury. Motor nerves in 5 dpf larvae demonstrate stable branching patterns and a degree 
of myelination roughly equal to that of a one week postnatal mouse (87,101,102). While 
this stage of larval development has many of the hallmarks of a mature motor nerve, it 
would also be useful to assess nerve regeneration in an even more mature animal. In 
our current experimental paradigm, nerves are transected in 5 dpf larvae and 
regeneration is assessed 48 hours later, when the larvae are 7 dpf. The ability to image 
older larvae would also allow us to assess nerve regeneration beyond 48 hours after 
transection. This would be useful for examining aspects of nerve regeneration that take 
longer than 48 hours, such as Schwann cell remyelination. 
As larvae mature from the early to the mid-larval stages, this is accompanied by 
substantial growth in terms of both length and thickness. At 5 dpf, the average length of 
a larva is 4 mm and by 15 dpf, the length increases to an average of 15 mm. This 
predominantly affects the number of fish that can be imaged simultaneously in a single 
imaging dish (Figure 3.2A). The greater consideration for imaging, however, is the 
thickness of the fish. As the fish grows, there is more tissue between the microscope 
objective and the spinal motor nerves, making it more difficult to image clearly. The 
larvae also have a more fully inflated swim bladder in the midlarval stages, making the 
trunk section substantially thicker than the tail section.  
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To determine how late the spinal motor nerves of midlarval zebrafish can be imaged 
using standard spinning disk confocal live imaging techniques, I raised larvae expressing 
mnx1:GFP to 21 dpf and imaged periodically from 5 dpf forward. I imaged motor nerves 
in both the midtrunk section (Figure 3.2B, box 1) as well as the tail (Figure 3.2B, box 2). I 
also transected these nerves at each timepoint to see in the laser could penetrate the 
tissue sufficiently in each location.  
At all timepoints (14, 16 and 19 dpf) nerves were successfully imaged and transected in 
both the midtrunk section as well as the tail (Figures 3.3, 3.4, 3.5). One challenge of 
nerve regeneration as an animal grows is that the distance across which an axon must 
regrow becomes much larger. The motor nerves of the trunk in the midlarval stages are 
much greater in length while the motor nerves of the tail are much shorter, and therefore 
a less useful tool to study more mature nerve regeneration. Surprisingly nerves in the 
midtrunk could be successfully imaged out to 19 days, after which point the full depth of 
the nerve could no longer be observed or imaged. This demonstrates that regeneration 
studies can be performed using the spinal motor nerves of the trunk in midlarval 
zebrafish until 19 dpf. 
Repeated nerve lesioning in vivo 
Another useful experimental paradigm enabled by the ability to image longer into the 
midlarval stages is a repeated lesioning model. The idea of conditioning lesions has 
been studied extensively in DRG neurons, which contain both CNS and PNS projecting 
axons. It has been found that if the PNS projection is first injured and allowed to recover, 
then the CNS projection is subsequently injured, the CNS axon will then regrow much 
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more robustly than typical CNS regeneration (103). This is thought to be caused by cell 
body changes in transcription that occur after the PNS injury, thus priming the cell body 
for regeneration and aiding in the regrowth of the CNS projection when it is subsequently 
injured. Conditioning lesions have also been seen to promote growth after subsequent 
lesions in the mouse rat peripheral nerves (104,105). Typically, a conditioning crush will 
be performed several days before the test crush, after which increased regeneration is 
observed.  
It is currently unknown whether conditioning lesions may promote subsequent regrowth 
of motor axons in the zebrafish. Furthermore, lesioning a nerve repeatedly may cause 
extra stress to the system and provide a sensitized condition in which to assay 
regeneration. In this case, if a particular gene has a milder contribution to axonal 
regrowth, we may be unable to see an effect on regeneration in our standard single 
transection assay but may see an effect in the repeated lesioning paradigm after 
transecting the same nerve multiple times.  
In order to determine whether motor nerves in larval zebrafish can regenerate in 
response to multiple lesions, I transected nerves in 5 dpf larvae, allowed them to regrow 
for 6 days, then transected the nerves again (Figure 2.6, A-D). I then assayed regrowth 
in response to the second lesion (Figure 2.6, E-H). I altered the site of transection from 
our standard single lesion assay, cutting more distally so that there would be sufficient 
regrowth to lesion a second time. This did in fact lead to robust regrowth 5 days after the 
first lesion, and again 4 days after the second lesion. Given that the animal grows quite 
dramatically in overall size throughout the course of this experiment (5 dpf, ~4 mm long 
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to 15 dpf, ~15 mm long), it is difficult to qualitatively compare the appearance of the 
nerve regrowth and determine whether regeneration is improved after a conditioning 
lesion. Experiments following up on this preliminary result should compare this regrowth 
to control animals that receive a single lesion at 11 dpf, without the conditioning lesion at 
5 dpf. These initial results demonstrate that larval zebrafish can survive, be imaged and 
have nerves transected throughout a 10 day assay in which both a conditioning lesion 
and test lesion are administered.  
Taken together, these experiments demonstrate an expanded potential of the zebrafish 
for assessing nerve regeneration in vivo, allowing us to examine later time points than 
before, as well as visualize subcellular components in Schwann cells.  
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Figure 3.1: Microtubule structure in Schwann cells in vivo. Schwann cell 
cytoskeletal structure in zebrafish larvae. (A) Tg(sox10:EB3-GFP) line 4, uninjured motor 
nerve of 2 dpf larvae; images taken every 5 seconds for 2 minutes and time projected 
(B) Tg(sox10:EB3-GFP) line 8, uninjured motor nerve 5 dpf larvae; images taken every 5 
seconds for 2 minutes and time projected (C) Tg(NBT:dsRed) labels axons in red, 
injected CldnK:EB3-GFP labels microtubule plus ends in green, uninjured motor nerve of 
5 dpf larvae; images taken every 10 mins for 5 hours and time projected. (D) Acetylated 
tubulin (green, microtubules) and znp1 (red, motor axons) stains in fixed 5 dpf larvae). 
(E-F) Tg(sox10:Gal4;UAS:EB3-GFP) in 5 dpf larvae, images taken every 10 seconds for 
2 minutes and time projected; in uninjured motor nerve (E) and 10 minutes post 
transection (F). 
  
54 
 
 
Figure 3.2: Schematic of mounting and imaging early and mid-larval zebrafish. (A) 
Placement of early (5 dpf) and midstage (14-19 dpf) larvae in glass bottom imaging 
dishes. (B) Enlargement of 5 dpf larvae; red box indicates imaging region of the ventral 
motor nerve in the midtrunk section, the standard nerve for transection in our 
regeneration studies. (C) Enlargement of a ~14-19 dpf larvae; red box 1 indicates ventral 
nerve imaging region in the midtrunk section, red box 2 indicates ventral motor nerve 
imaging region in the tail section. 
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Figure 3.3: Midlarval imaging in 14 dpf zebrafish. Tg(Hb9:GFP) labeling ventral motor 
nerves. (A-B) Motor nerve in mid-trunk section before (A) and immediately after (B) laser 
transection. (C-D) Motor nerve in tail section before (C) and immediately after (D) laser 
transection. Motor nerves can be imaged and transected successfully in both areas.  
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Figure 3.4: Midlarval imaging in 16 dpf zebrafish. Tg(Hb9:GFP) labeling ventral motor 
nerves. (A-B) Motor nerve in mid-trunk section before (A) and immediately after (B) laser 
transection. (C-D) Motor nerve in tail section before (C) and immediately after (D) laser 
transection. Motor nerves can be imaged and transected successfully in both areas. 
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Figure 3.5: Midlarval imaging in 19 dpf zebrafish. Tg(Hb9:GFP) labeling ventral motor 
nerves. (A-B) Motor nerve in mid-trunk section before (A) and immediately after (B) laser 
transection. (C-D) Motor nerve in tail section before (C) and immediately after (D) laser 
transection. Motor nerves can be imaged and transected successfully in both areas. 
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Figure 3.6 Repeated nerve lesioning in zebrafish larvae. Wild type larvae, motor 
axons labeled with Tg(mnx1:GFP). (A) Pre-lesion motor nerve at 5 dpf, red box shows 
site of transection. (B) Motor nerve at 5 dpf, 6 hours after first lesion. (C) Motor nerve at 
8 dpf, 72 hours after first lesion. (D) Motor nerve at 11 dpf, 120 hours after first lesion; 
red box shows site of second transection. (E) Motor nerve at 11 dpf, 0 hours after 
second lesion. (F) Motor nerve at 11 dpf, 6 hours after second lesion. (G) Motor nerve at 
13 dpf, 48 hours after second lesion. (H) Motor nerve at 15 dpf, 96 hours after second 
lesion.  
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CHAPTER 5: MATERIALS AND METHODS 
Ethics statement  
All experiments were conducted according to an Animal Protocol fully approved by the 
University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) on 
January 24, 2014, protocol number 803446. Veterinary care is under the supervision of 
the University Laboratory Animal Resources (ULAR) of the University of Pennsylvania.  
Zebrafish genetics and transgenes  
All transgenic lines were maintained in the Tübigen or Tupfel long fin genetic 
background and raised as previously described(106). Transgenic lines used are listed in 
Table 5.1. Mutant lines used are listed in Table 5.2. Genotyping primers are listed in 
Table 5.3. 
Table 5.1: Transgenic lines. 
Transgenic Lines Population labeled Source 
Tg(mnx1:GFP)ml2 Spinal motor neurons (107) 
Tg(sox10(7.2):mRFP)vu234 Schwann cell membranes (12) 
Tg(UAS:lifeact-GFP-v2a-
EB3-RFP) 
Microtubule plus ends 
(red) and actin (green) 
Bremer et. al., in 
preparation 
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Tg(sox10:EB3-GFP) line 4 Microtubule plus ends generated 
Tg(sox10:EB3-GFP) line 8 Microtubule plus ends generated 
Tg(Xla.Tubb:dsRed) Pan-neuronal (108) 
 
Table 5.2: Mutant lines. 
Mutant Mutation Source 
dync1h1hi3684Tg Viral intronic insertion, 
presumed null from 
nonsense-mediated decay 
(109) 
gpr126stl47 Indel causing frameshift 
and early truncation 
(110) 
kif5Aasa7168  Point mutation in essential 
splice site donor 
(111) 
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Table 5.3: Genotyping primers. 
Mutant Genotyping primers Reference 
dync1h1hi3684Tg F1: 5’-AAACCTACAGGTGGGGTCTTTC-3’ 
F2: 5’-CATGAACGTGGCGCTGGTAC-3’ 
R: 5’-GFTACAACTACGAGCAAGTCAACC-3’ 
(109) 
gpr126stl47 F: 5’-GTCTTTGTCTCTGTCGATGC-3’ 
R: 5’:-GCTTGTAACTGATATGGAAGCC-3’ 
(110) 
kif5Aasa7168 F: 5’-TGGAGAAACGTCTTCGTTCTACG-3’ 
R1: 5’-GTGTGTGAATGTGAATGCAGTGCACAGTGT-3’ 
R2: 5’-GTGTGTGAATGTGAATGCAGTGCACCAGCGT-3’ 
(111) 
 
Nerve transection and live imaging  
Nerve transection and live imaging were performed as previously described (51,52).  
Axon growth extent quantification  
Axon growth extent quantification was performed as previously described (52). 
Transected nerves in which axons failed to regrow or did not extend through the entire 
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length of the ventral myotome are categorized as “no/weak regeneration.” Nerves with at 
least one fascicle that extended through the entire length of the ventral myotome are 
categorized as “moderate regeneration.” Finally, nerves with two or more fascicles 
extending through the entire length of the ventral myotome are categorized as “strong 
regeneration.”  
Axon extension and retraction quantification  
Axons were imaged every 15 minutes from ~7 to ~16 hpt. Extensions and retractions 
were defined as growth or retraction of >1 μm between timelapse frames and number of 
extension and retraction events was counted. Continued movements of the same 
direction in a subsequent frame were not counted as new events. Measurements were 
performed on each visibly distinct axon in a nerve.  
Growth cone displacement quantification  
Axons imaged at ~16 hpt were measured by drawing a line from the spinal cord exit 
point to the growth cone. Measurements were performed on each visibly distinct axon in 
a nerve.  
Schwann cell width quantification  
Axons and Schwann cells were imaged before transection and every 15 minutes from ~1 
to ~5 hpt. Schwann cell width was measured at the widest point in pre- and post-
transection images. Using ImageJ, a line was drawn from one edge of the Schwann cell 
membrane to the other in an orientation perpendicular to the motor nerve and was 
measured in microns.  
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Cell transplantation for chimera analysis 
Cell transplantations were performed as previously described (32). Wild type cells were 
transplanted into dync1h1-/- embryos in areas known to develop into motor neurons. 
Larvae were screened at 5 dpf to identify nerves that contained transplanted motor 
neurons and no other transplanted cell types along the path of the ventral motor nerve. 
Transection, imaging, and quantification of growth cone displacement in identified 
nerves were performed as described above.  
Image processing  
Image stacks were compressed into maximum intensity projections (MIPs) in Slidebook 
6 then processed using ImageJ and Photoshop to normalize brightness and contrast. 
Statistical analysis  
Fisher’s exact and Student’s t tests were performed on all applicable datasets.  
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CHAPTER 6: DISCUSSION 
Molecular motors Kinesin-1 and Dynein are required for nerve regeneration in vivo 
Microtubule-associated motors are critical for cellular maintenance, transporting 
important cargos throughout a cell and also helping to modulate the dynamics of the 
microtubules that they travel along. Previous studies have demonstrated a role for both 
the anterograde motor kinesin-1 and the retrograde motor dynein in establishing 
microtubule organization in developing axons. Additionally, many previous studies have 
found that dynein is critical in transporting signaling complexes from the axon to the cell 
body after injury. While this role for dynein in axonal regrowth has previously been 
described, kinesin-1 and dynein have many cellular cargos and functions, raising the 
possibility that these motors may be involved in nerve regeneration in multiple 
capacities. Furthermore, studies of the dynein-dependent retrograde injury signal have 
focused exclusively on the requirement for dynein in the axon. While neurons are known 
to be particularly dependent on active transport for cellular maintenance due to their 
length and highly polarized morphology, kinesin-1 and dynein are also critical in many 
other cell types. As such, we sought to evaluate the role of kinesin-1 and dynein in a 
multicellular context, using live-imaging in the zebrafish larvae to assess nerve 
regeneration in a live, whole organism.  We took advantage of homozygous zebrafish 
mutants for the kif5aa and dync1h1 genes, since their motor nerves developed normally 
due to maternal contribution. By transecting these nerves and imaging the regeneration 
48 hours later, we showed for the first time a requirement for both kinesin-1 and dynein 
in peripheral nerve regeneration in vivo.  
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Dynein stabilizes axonal extensions during regeneration  
Nerve injury induces a local signaling cascade that leads to the production of axon 
intrinsic signals at the lesion site (112). There is overwhelming evidence that dynein is 
critical to transport these injury signals from the lesion site to the cell body where they 
initiate a neuronal injury response (113-115). We find that in presumptive dynein null 
mutants, injured neurons robustly respond to the injury and within ~8-10 hours, 
regenerating axons sprout from the proximal stump, indistinguishable from what we 
observe in wild type animals. This raises the question whether axonal sprouting can 
occur independently of dynein-dependent injury dependent signals, or whether in our 
zebrafish model dynein-mediated retrograde transport is less important to mount an 
injury response. One clear difference between rodent models and our model is the 
distance between the injury site and the neuronal cell bodies. In rodent sciatic nerve 
models lesions are introduced millimeters away from neuronal cell bodies (115), while in 
larval zebrafish – due to the smaller animal size – lesions are generated about 10-50 μm 
away from neuronal cell bodies (51) Thus, it is conceivable that due to the almost 100-
fold reduction in distance between lesion site and cell body, injury signal propagation 
from the lesion site to the cell body is less dependent on dynein function. Although it 
remains unclear how injury signal propagation can occur independent of dynein, this 
provided us with the unique opportunity to examine dynein’s role in peripheral nerve 
regeneration beyond its role in injury signal transport.  
Endpoint analyses at 48 hpt uncovered a clear role for dynein in peripheral nerve 
regeneration, with clear effects on both axonal regrowth and Schwann cell injury 
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response (Figures 2.1 and 2.3). Using live-imaging to visualize the early stages of the 
regeneration process, we found that dynein promotes the stabilization and growth of 
long-range axonal projections, providing compelling evidence that apart from its well-
documented role in retrograde injury signal transport, dynein also plays a critical role in 
sustaining axonal regrowth.  
Dynein is required for Schwann cell remodeling after injury 
In addition to the axonal regrowth defects observed in dynein mutants, simultaneously 
visualizing the cellular behavior of both axons and Schwann cells revealed that loss of 
dynein also prevented injury-induced Schwann cell remodeling. The transition of 
Schwann cells from their fully differentiated state to a repair cell state is a well-
documented and integral aspect of peripheral nerve regeneration (95,116), accompanied 
by dramatic morphological changes to the Schwann cell, as the cell breaks down its 
myelin and extends its membrane to engulf axonal debris (117,118). Dynein regulates 
several steps of membrane trafficking, including ER to Golgi transport, as well as 
endosomal trafficking (119), so it is conceivable that dynein plays a direct, cell-
autonomous role in this process. Alternatively, the inability of Schwann cells to initiate 
the remodeling process might be a consequence of strongly reduced axonal regrowth, 
and future experiments will be required to test a possible Schwann cell-specific role for 
dynein in the remodeling process. Of these two possibilities, however, it seems most 
likely that dynein is playing a role specifically in the Schwann cell to promote remodeling 
after injury. This is due to the timing of Schwann cell remodeling, which occurs at the 
time of axonal fragmentation, hours before axonal regrowth begins. It is, however, 
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possible that axon-Schwann cell communication before injury is critical to prime 
Schwann cells to respond to injury, and this communication may be disrupted by the 
absence of dynein and a potential impairment in signaling endosome transport, etc.  
The absence of Schwann cell remodeling in dynein mutants also reveals novel insights 
into the mechanism of Schwann cell injury response. It has previously been thought that 
the morphological changes occurring in Schwann cells after injury result simply from the 
loss of axonal tension as the distal axons fragment. However, we observe in dynein 
mutants that even as distal axons fragment following injury, the Schwann cells do not 
respond with characteristic morphological changes. This indicates that mechanical 
forces alone are insufficient to induce the morphology changes observed in Schwann 
cells after injury, and suggests that molecular and genetic mechanism drive this repair 
cell transition both transcriptionally and morphologically.  
This raises another interesting question regarding the relationship between Schwann cell 
differentiation state and morphology changes after injury – does a change in Schwann 
cell morphology after injury necessarily indicate that the transcriptionally regulated repair 
cell transition has occurred, and vice versa? One way to address this question is to 
assess the transcriptional state of dynein mutant Schwann cells after injury. While we 
know that dynein mutant Schwann cells do not respond morphologically to injury, it is 
possible that the appropriate transcriptional response towards the repair cell state still 
occurs. The repair cell state is characterized by both dedifferentiation and activation 
processes. Difficulties arise when trying to assess the repair cell transition 
transcriptionally in dynein mutants, however, as these mutants also have defects that 
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prevent full differentiation during development. As a result, many of the markers of the 
repair cell transition are developmental marker that become re-expressed during the 
transition to the repair cell state, such as Sox2 (120). Unfortunately, these markers never 
actually become downregulated in the 5 dpf dynein mutant Schwann cells as the animal 
matures. Thus, it will be critical to use transcriptional markers that are unique to the 
repair cell state and are not simply developmental markers that are re-expressed after 
injury, but rather distinct markers of Schwann cell activation after injury. One candidate 
marker is c-Jun and its downstream targets, which are expressed at low levels in 
Schwann cells developmentally but become highly expressed after injury (95,116).  
In addition to further characterizing the repair cell transition by assessing transcriptional 
changes that occur in Schwann cells after injury, it will also be useful to examine 
cytoskeletal changes that occur after injury in both wild type and mutant animals. Using 
the tools and techniques developed in Chapter 3, we can first assess the cytoskeletal 
changes that drive Schwann cell remodeling in wild type animals. We can subsequently 
assess the cytoskeleton in dynein mutant Schwann cells and determine whether any 
cytoskeletal changes are initiated after injury, though the gross morphology does not 
change appreciably. Together, these experiments will help determine to what extent the 
cytoskeletal and morphological changes in Schwann cells after injury dictate the 
transition to the repair cell state.  
Neuronal dynein is sufficient to promote axonal regrowth after injury 
Given that dynein mutants exhibit defects in axonal regrowth and Schwann cell 
morphology, we performed chimeric analysis experiments to determine in which cell type 
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dynein is required to promote nerve regeneration in vivo. These experiments revealed 
that dynein function in injured neurons is sufficient to sustain axonal regeneration. 
Importantly in our chimera experiments, of the roughly 60 axons contributing to an 
individual motor nerve (121), on average only 1-3 transplanted wild type axons were 
present. This low level of chimerism was critical to evaluate regrowth capacity of 
individual wild type axons. This also revealed that the presence of individual wild type 
axonal regrowth facilitated regrowth of individual, neighboring dynein deficient axons 
(Figure 2.4, G-I). At the same time, the low level of chimerism precluded us from asking 
whether neuronal dynein restored all aspects of peripheral nerve regeneration, including 
injury-induced Schwann cell remodeling. Thus, while neuronal dynein plays a critical role 
in sustaining axonal regrowth, we cannot exclude the possibility that dynein function in 
Schwann cells also contributes to peripheral nerve regeneration.  
Dynein promotes axonal regeneration by modulating microtubule dynamics 
Cytoskeletal dynamics are critical to growth cone formation (122), axonal outgrowth 
during development (123), and axonal regeneration (124). Previous studies have 
revealed that microtubule stabilization promotes axonal regrowth after injury both in vitro 
and in vivo (125-127). Interestingly, studies of C. elegans dynein heavy chain mutants 
recently revealed that dynein acts locally in dendrites to stabilize microtubules (74). This 
raised the possibility that dynein may also act locally in regenerating axons to stabilize 
microtubules. We assessed cytoskeletal dynamics during regeneration using a 
transgene that allowed us to visualize actin and microtubules simultaneously in live, 
regenerating axons. This revealed that while actin dynamics were grossly unaffected in 
dynein mutant axons, microtubules often appeared unstable and disordered, with some 
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axons exhibiting looping microtubule configurations reminiscent of those seen in the 
dendrites of C. elegans dynein heavy chain mutants (74). Thus, our results provide 
compelling evidence that besides its well-documented role in retrograde transport, 
dynein also promotes microtubule stability critical for growth cone advancement (128), 
providing a potential mechanism for the rapid and sustained extension observed during 
wild type axonal regrowth, and deficient in dynein mutants (Figure 2.6).  
Dynein is also known to play a role in microtubule sliding (129), providing an alternative 
mechanism through which dynein may modulate axonal microtubule dynamics during 
regeneration. This may be a direct effect of dynein specifically interacting with 
microtubules, as it has previously been shown that dynein slides microtubules in a 
polarity-sorting manner during axon outgrowth. It is conceivable that dynein has this 
same role during axonal regrowth after injury and that in the absence of dynein, the 
polarity of microtubules in the axon is not established properly and eventually leads to 
retraction of the axonal extension. This idea is consistent with the axonal extension 
phenotype we observe in the dynein mutants, in which axonal extension proceeds for a 
short distance before becoming destabilized and retracting.  
Another possibility is that dynein may affect microtubule sliding indirectly via modulation 
of kinesin-1, as these motors have been shown to transport each other directly (130). 
Some studies in culture have shown that severe disruption of the anterograde motor 
kinesin-1 can disrupt dynein-dependent transport, and vice versa. Further studies will be 
required to determine whether dynein’s role in promoting axonal outgrowth specifically 
affects microtubule sliding, and whether this effect is through a direct microtubule 
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interaction or the modulation and transport of the anterograde motor, kinesin-1, which 
has previously been found to power microtubule sliding during axonal outgrowth. 
One remaining question regarding the role of dynein in modulating microtubule dynamics 
after injury is whether dynein is a direct effector of microtubule dynamics, or whether 
microtubule dynamics are simply a downstream effector of the retrograde injury signals  
activated after injury. As discussed previously, we have not yet been able to determine 
whether critical retrograde injury signals arrive at the cell body in the absence of dynein. 
While the scale of the injury model in the zebrafish suggests that activated retrograde 
injury signals can likely reach the cell body without active transport by dynein, it is still 
possible that critical signals, such as p-JNK, are disrupted in the dynein mutant. It has 
previously been shown that microtubules are downstream effectors of JNK signaling to 
promote neurite outgrowth (131,132). In order to determine whether dynein is directly 
affecting microtubule dynamics, it will be important to determine whether critical 
retrograde injury signals such as p-ERK and p-JNK are detected in the cell bodies of 
dynein mutant motor neurons after injury. Experiments are underway to visualize p-JNK 
and p-ERK via antibody staining, and I have also obtained a construct for fluorescently 
tagged p-JNK that can be used to visualize p-JNK in motor neurons after injury (133). 
Experiments to test the direct interaction between dynein and microtubules in the 
regrowing axon will be challenging, as dynein interacts with microtubules in its 
microtubule binding domain for all cargo transport functions, as well as microtubule 
sliding. An interesting experiment to further probe dynein’s role in modulating 
microtubule dynamics during axonal regrowth is to use taxol to stabilize microtubules in 
dynein mutant larvae. If the critical role for dynein in promoting axonal regrowth is in fact 
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modulation of microtubule dynamics, we would expect that stabilization of microtubules 
by taxol could rescue the axonal regrowth defects observed in dynein mutant nerves.  
If it is confirmed that dynein is directly affecting microtubule dynamics in the regrowing 
axon after injury, the nature of its interaction with microtubules should be examined. One 
possibility is that dynein impacts microtubule stability, while another is that dynein is 
critical for establishing appropriate microtubule polarity during axon outgrowth, as in 
development. To distinguish between these functions, microtubule polarity should be 
examined in regrowing axons. If dynein is indeed acting to slide microtubules in a 
polarity-dependent manner, we would expect to see disrupted microtubule polarity in the 
regrowing axons of dynein mutants. These experiments will help determine the specific 
nature of dynein’s role in modulating axonal microtubule dynamins after injury. 
Dynein in cytoskeletal maintenance: insight for human disease 
Multiple mutations in the dynein heavy chain, DYNC1H1, have been found to cause 
neurodegenerative conditions in human patients, indicating a critical role for the motor 
dynein in neuronal homeostasis and maintenance. First, a dominant point mutation in 
the homodimerization domain of DYNC1H1 was found to cause axonal Charcot-Marie-
Tooth disease in a large family pedigree (44). Additionally, two dominant mutations in 
the tail domain of DYNC1H1 have been found to cause spinal muscular atrophy (SMA) 
(43), and biochemical analysis revealed that these mutations disrupted complex stability 
and function.  
Thus far, insights into the disease mechanism of these human mutations have come 
from biochemical analysis in vitro as well as endpoint analysis of mouse mutants. The 
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heterozygous dync1h1 mutants may provide another unique entry point into studying the 
role of dynein in neuronal maintenance in vivo. The zebrafish dync1h1hi3684 mutation is 
an intronic viral insertion in the motor domain of the dynein heavy chain, which is 
expected to disrupt function and stability of the dynein complex (77). These 
heterozygous dynein mutants are fully viable into adulthood, however our preliminary 
results have revealed that cytoskeletal organization of the axon is severely disrupted in 
these mutants (Figures 2.7, 2.8). This cytoskeletal disruption suggests a potential 
mechanism for the axonal degeneration observed as a result DYNC1H1 mutations in 
humans.  
Interestingly, there are no obvious defects in the motor function of the heterozygous 
dynein mutant zebrafish, despite their disrupted cytoskeletal structure. One possibility is 
that these cytoskeletal defects do not disrupt axonal function, however this seems 
unlikely since relatively minor mutations in cytoskeletal proteins can lead to severe 
axonal degeneration in human and mouse mutants (Table 1.1). Another possibility is that 
these adult heterozygotes have motor defects that are imperceptible without a closer 
method of study. To determine whether dync1h1 heterozygotes have any functional 
motor deficits, we can examine the startle response at larval, juvenile, and adult stages 
as previously described by and developed in our lab. This will reveal whether there is 
any developmental deficit in these animals, and additionally determine whether motor 
function degenerates over time.  
To complement these studies, we can also perform electron microscopy on motor 
nerves at each of these stages and quantify the number of axons in a given nerve. This 
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should be another indication of whether axonal degeneration is occurring in these 
animals, as we would expect the number of axons per nerve to decrease over time as a 
result of degeneration. As mentioned previously, we can also examine cytoskeletal 
structure in the axons at each of these stages to determine whether the cytoskeleton is 
disrupted during development or degenerates over time, and additionally correlate this to 
any functional deficits or axonal loss that is observed.  
To further assess the cytoskeletal structure in axons of dynein heterozygotes, we can 
use the fluorescently tagged cytoskeleton line described in Chapter 2 (Figure 2.6; 
Tg(mnx1:Gal4) x Tg(UAS:EB3-RFP-lifeact-GFP)) combined with the midlarval imaging 
techniques described in Chapter 3. This will allow us to monitor the axonal cytoskeleton 
from the time of axon outgrowth in development through the midlarval stages, and 
should reveal whether the axonal cytoskeleton in dynein heterozygotes is established 
correctly in development, and also whether it degenerates over time. These experiments 
may provide new insights into the disease mechanism of degenerative diseases caused 
by dynein mutations, and may reveal that in addition to directing transport, dynein helps 
establish and/or maintain cytoskeletal structure in axons. 
Dynein promotes axonal degeneration after injury 
While studies in human and mouse have revealed a role for dynein in neuronal 
maintenance at homeostasis, our experiments revealed an additional role for dynein in 
the active process of Wallerian degeneration. Following nerve injury, we observed that 
dynein mutant axons in the distal stump show an extended lag phase prior to axonal 
fragmentation, indicating that dynein promotes Wallerian degeneration. Previous studies 
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of axonal degeneration have found that upon nerve crush or transection, cargos 
traveling retrogradely in the axon accumulate just distal to the site of injury as they can 
no longer pass into the proximal axon segment. This phenomenon has often been 
considered from the perspective of the cell body and proximal axon – that this 
accumulation of cargos distally subsequently results in a lack of these cargos and 
signals in the proximal nerve segment. Given that dynein affects the timing of axonal 
fragmentation in the distal stump, it seems it may have a more active function in the 
distal part of the nerve than previously thought.  
One possibility is that cargo accumulation at the end of the distal nerve segment 
somehow induces Wallerian degeneration. In the absence of dynein, we would expect 
that cargo distribution is already disrupted and the change after injury would be less 
pronounced. Given that Wallerian degeneration is a process initiated by active death 
signals in the axon, it is also possible that dynein-mediated transport is required for the 
distribution of relevant signals through the axon to coordinate axonal fragmentation. 
Notably, when axonal fragmentation occurs, the entire length of the axon fragments at 
the same time, suggesting tight temporal and spatial regulation of the fragmentation 
process. Given dynein’s key role in controlling the spatial distribution of critical cellular 
cargos, it is tempting to speculate that dynein’s role in promoting Wallerian degeneration 
is related to this function. 
One specific cargo of dynein that may be particularly critical for Wallerian degeneration 
is the autophagosome. In neurons, autophagosomes initiate distally and enclose cellular 
contents to be degraded. They then complex with dynein and travel retrogradely where 
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they fuse with lysosomes and degrade their contents. The process of autophagy is likely 
disrupted in that axons of dynein mutants, and this could be one explanation for the 
disrupted axonal fragmentation that is observed. It is conceivable that in addition to 
engulfment by macrophages and Schwann cells, the axonal debris generated upon 
fragmentation is also in part degraded by the neuron itself. This would process would 
likely occur prior to fragmentation while the axons are still intact, and could represent 
one functional benefit of the lag phase observed in Wallerian degeneration. Further 
studies will be required to determine whether autophagosome distribution and function is 
observed in dynein mutant axons. Additionally, it will be important to determine whether 
specifically disrupting autophagy affects the timing of axonal fragmentation after injury.  
The preliminary studies described here are the first demonstration that the molecular 
motor dynein promotes the process of Wallerian degeneration following injury in vivo. 
Follow up studies will reveal more about the specific mechanism by which dynein 
controls the precise timing of axonal fragmentation. 
Conclusions 
The work in this thesis demonstrates novel roles for the motor proteins kinesin-1 and 
dynein in peripheral nerve regeneration in vivo. It identifies additional mechanisms, 
beyond the transport of retrograde injury signals, by which dynein promotes axonal 
regrowth. It also provides preliminary evidence that dynein promotes cytoskeletal 
maintenance in axons as well as degeneration after injury, and suggests potential 
mechanisms of these roles. Taken together, these studies reveal previously unknown 
functions of dynein in peripheral nerve de- and regeneration.  
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